1
|
Zuniga L, Davis M, Movahed MR, Hashemzadeh M, Hashemzadeh M. Association between Factor-V Leiden and occurrence of acute myocardial infarction using a large NIS database. AMERICAN JOURNAL OF BLOOD RESEARCH 2023; 13:207-212. [PMID: 38223312 PMCID: PMC10784119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 05/27/2023] [Accepted: 12/22/2023] [Indexed: 01/16/2024]
Abstract
Factor V Leiden is an inheritable pro-thrombotic genetic condition caused by a point mutation at the 506th codon, resulting in activated protein C resistance. APC resistance has been shown to contribute to the development of venous thrombosis. However, the role of FVL in AMI has yet to be well defined in the current literature. To assess whether a mutation carrier is more apt to develop an AMI, we conducted a retrospective observational analysis of two populations aged 18-40 and 18 through end of life. We used ICD-10 codes to search the NIS, an electronic nationwide patient database, to establish our populations and obtain our data. The ICD-10 codes were specific for activated protein C resistance and acute myocardial infarction. Preliminary data indicated that FVL was related to AMI; however, this finding became insignificant in both populations when stratified for age. We concluded there was no association between Factor V Leiden and acute myocardial infarction across both examined populations. Future investigations into this field of research are warranted as there remains a need for more consensus among the scientific community. BACKGROUND Medical literature regarding the correlation between Factor V Leiden (FVL) and acute myocardial infarctions (AMI) is controversial. We aim to investigate the association between FVL and AMI. MATERIALS AND METHODS Using the Nationwide Inpatient Sample database, we evaluated any association between Factor V Leiden and acute myocardial infarction in 2016 using ICD-10 codes. RESULTS Univariate analysis (18-40) showed an increase of AMI in patients with FVL 0.6% vs. 0.4%. However, after adjustment for age and comorbid conditions in multivariate analysis, FVL was not significantly associated with acute myocardial infarction (OR 1.44 (95% CI 0.913-2.273, p-value 0.117)). Univariate analysis (all patients over 18 years old) found that 2.9% of patients with FVL experienced AMI vs. 4.4% without the mutation. Multivariate analysis of the entire population ultimately showed no correlation between FVL and AMI. CONCLUSION In a population over 18, Factor V Leiden did not correlate with an increased risk of acute myocardial infarction in our studied population.
Collapse
Affiliation(s)
- Luis Zuniga
- University of Nebraska Medical CenterOmaha, NE, USA
| | - Mitchell Davis
- Department of Dermatology, University of CaliforniaSan Francisco, CA, USA
| | - Mohammad Reza Movahed
- College of Medicine, University of ArizonaPhoenix, AZ, USA
- College of Medicine, University of ArizonaTucson, AZ, USA
| | | | - Mehrnoosh Hashemzadeh
- College of Medicine, University of ArizonaPhoenix, AZ, USA
- Pima Community CollegeTucson, AZ, USA
| |
Collapse
|
2
|
Msalati A, Bashein A, Ghrew M, Khalil I, Sedaa K, Ali A, Zaid A. Association of venous thromboembolism and myocardial infarction with Factor V Leiden and Factor II gene mutations among Libyan patients. Libyan J Med 2021; 16:1857525. [PMID: 33470184 PMCID: PMC7833017 DOI: 10.1080/19932820.2020.1857525] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Abstract
Factor V Leiden G1691A (FVL) and Factor II prothrombin G20210A (PGM) mutations are the leading causes of thrombophilia. In this study, we have investigated the prevalence of the FVL G1691A and PGM G20210A single nucleotide polymorphisms (SNPs) among Libyan deep vein thrombosis (DVT) and myocardial infarction (MI) patients. SNP genotyping was performed using high-resolution melt analysis (HRM) and DNA sequencing. Biochemical parameters conducted on 112 males and 93 females showed no significant difference in means between the control group and the deep vein thrombosis and myocardial infarction groups. For Factor V Leiden, 40 samples were genotyped. Of the 40 samples, 6 (15.0%) of them were heterozygous and no one was homozygous. As for Factor II SNP, 59 samples were genotyped and only 2 (3.3%) were heterozygous. All the heterozygous samples showed 100% concordance between the HRM-PCR and DNA sequence analysis. Our study showed, for the first time, that both the FVL and PGM mutations are present among Libyan DVT and MI patients and that the FVL mutation is significantly associated with DVT but not with MI. However, our results do not support the association of PGM G20210A mutation with DVT or MI.
Collapse
Affiliation(s)
- Abdulghani Msalati
- Department of Biochemistry & Molecular Biology, Faculty of Medicine, University of Tripoli , Tripoli, Libya
| | - Abdulla Bashein
- Department of Biochemistry & Molecular Biology, Faculty of Medicine, University of Tripoli , Tripoli, Libya
| | - Murad Ghrew
- Faculty of Biology, Medicine and Health, University of Manchester , UK
| | - Ibtesam Khalil
- Department of Biochemistry, Laboratory of Tripoli University Hospital , Tripoli, Libya
| | - Khaled Sedaa
- Department of Biochemistry & Molecular Biology, Faculty of Medicine, University of Tripoli , Tripoli, Libya
| | - Abushawashi Ali
- Department of Surgery, Faculty of Medicine, University of Tripoli , Tripoli, Libya
| | - Ahmed Zaid
- Department of Biochemistry & Molecular Biology, Faculty of Medicine, University of Tripoli , Tripoli, Libya
| |
Collapse
|
3
|
Mitochondrial Genome Mutations Associated with Myocardial Infarction. DISEASE MARKERS 2018; 2018:9749457. [PMID: 29670672 PMCID: PMC5835263 DOI: 10.1155/2018/9749457] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 09/22/2017] [Revised: 12/08/2017] [Accepted: 01/23/2018] [Indexed: 01/20/2023]
Abstract
Myocardial infarction is one of the clinical manifestations of coronary heart disease. In some cases, the cause of myocardial infarction may be atherosclerotic plaques which occurred in the human aorta. The association of mtDNA mutations with atherosclerotic lesions in human arteries was previously detected by our research group. In this study, we used samples of white blood cells collected from 225 patients with myocardial infarction and 239 control persons with no health complaints. DNA was isolated from the blood leukocyte samples. Then, PCR fragments of DNA were obtained. They contained the investigated regions of 11 mitochondrial genome mutations (m.5178C>A, m.3336T>C, m.652delG, m.12315G>A, m.14459G>A, m.652insG, m.14846G>A, m.13513G>A, m.1555A>G, m.15059G>A, m.3256C>T). According to the obtained results, three mutations of the human mitochondrial genome correlated with myocardial infarction. A positive correlation was observed for mutation m.5178C>A. At the same time, a highly significant negative correlation with myocardial infarction was observed for mutation m.14846G>A. One single-nucleotide substitution of m.12315G>A had a trend towards negative correlation. These mutations can potentially be useful for creating molecular/cellular models for studying the mechanisms of myocardial infarction and designing novel therapies. Moreover, these mutations can possibly be used for diagnostic purposes.
Collapse
|
4
|
Baghad I, Erguibi D, Chehab F, Nadifi S. Risk of colorectal cancer and clotting factor gene polymorphisms in Moroccan Population. ACTA ACUST UNITED AC 2018; 5:1141-1146. [PMID: 29354651 DOI: 10.21474/ijar01/5166] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Background Venous thrombosis has been described as a common complication for cancer patients. The association between clotting factor gene polymorphisms and the risk of colorectal cancer has been evidenced. The aim of the present study was to investigate the association of G20210A factor II prothrombin (FII) and factor V Leiden ( FVL) G1691A with the risk of colorectal cancer(CRC). Methods and results Genotyping of FVL and G20210A FII was performed using the polymerase chain reaction restriction fragment length polymorphism method on a sample of 76 patients with CRC as well as 182 controls. No significant difference in FVL gene variations was observed between cases and controls. However, with regard to the G20210A FII, the homozygous mutated genotype AA was associated with an increased risk of CRC. A significant association between the G20210A FII mutation and the risk of CRC was identified using recessive (OR=57.63, 95% CI: 3.33-997.26, P=0.0053), dominant (OR=27.87, 95% CI: 12.67 -61.28, P<0, 0001) and additive (OR=21.24, 95% CI: 10.45-43.16, P<0, 0001) models. No statistical difference was observed in parameters such as sex, age and positive family history for cancer. Conclusion Our results did not support an effect of FVL gene on CRC risk and suggested that the G20210A FII prothrombin gene variant may be a risk factor for CRC in Moroccan population.
Collapse
Affiliation(s)
- Imane Baghad
- A PhD student of Centre of Doctoral study in health science-Doctoral training in genetics and molecular pathology -Laboratory of Genetics and Molecular Pathology, Medical School, University Hassan II, Casablanca BP 9154, Morocco
| | - Driss Erguibi
- General Surgery Department III, Ibn Rochd University Hospital Center, Casablanca BP 20102, Morocco
| | - Farid Chehab
- General Surgery Department III, Ibn Rochd University Hospital Center, Casablanca BP 20102, Morocco
| | - Sellama Nadifi
- Laboratory of Medical Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco
| |
Collapse
|
5
|
Hmimech W, Idrissi HH, Diakite B, Korchi F, Baghdadi D, Tahri Joutey Hassani Idrissi H, Haboub M, Habbal R, Nadifi S. Impact of I/D polymorphism of angiotensin-converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients. BMC Res Notes 2017; 10:763. [PMID: 29268798 PMCID: PMC5740925 DOI: 10.1186/s13104-017-3039-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2017] [Accepted: 11/30/2017] [Indexed: 11/13/2022] Open
Abstract
Objective Our case–control study aimed to access the potential association of insertion/deletion (I/D) ACE (angiotensin converting enzyme) gene polymorphism with myocardial infarction (MI) risk of occurrence among a sample of Moroccan patients, especially young ones. Results Distribution of I/D ACE gene variant among cases vs controls, showed that healthy controls carried out higher frequency of wild type allele I compared to cases (23.5% vs 21.79% respectively), when cases were carrying higher frequency of mutant allele D (78.21% vs 76.5% for controls). Patients were-after this- divided into two groups of < 45 and > 55 years of age, to investigate whether or not younger patients carried out higher frequency of the mutant allele D, than older ones. As expected, < 45 years old patients carried out more DD genotype than older ones (68.9% vs 54.6% respectively), and higher frequency of mutant allele D (81.08% vs 75% respectively). Besides, a tendency to a positive association was found under the recessive genetic transmission model (OR [95% CI] = 1.85 [0.93–3.69], P = 0.08), suggesting that the I/D ACE polymorphism may be associated with MI occurrence among younger patients (< 45 years of age). Electronic supplementary material The online version of this article (10.1186/s13104-017-3039-1) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Wiam Hmimech
- Laboratory of Genetics and Molecular Pathology, Medical School, University Hassan II, 19, Street TarikIbnouZiad, B. P: 9154, Casablanca, Morocco
| | - Hind Hassani Idrissi
- Laboratory of Genetics and Molecular Pathology, Medical School, University Hassan II, 19, Street TarikIbnouZiad, B. P: 9154, Casablanca, Morocco.
| | - Brehima Diakite
- Laboratory of Genetics and Molecular Pathology, Medical School, University Hassan II, 19, Street TarikIbnouZiad, B. P: 9154, Casablanca, Morocco
| | - Farah Korchi
- Department of Cardiology, University Hospital Center IbnRochd, Casablanca, Morocco
| | - Dalila Baghdadi
- Department of Cardiology, University Hospital Center IbnRochd, Casablanca, Morocco
| | | | - Meriem Haboub
- Department of Cardiology, University Hospital Center IbnRochd, Casablanca, Morocco
| | - Rachida Habbal
- Department of Cardiology, University Hospital Center IbnRochd, Casablanca, Morocco
| | - Sellama Nadifi
- Laboratory of Genetics and Molecular Pathology, Medical School, University Hassan II, 19, Street TarikIbnouZiad, B. P: 9154, Casablanca, Morocco
| |
Collapse
|